Alpenglow Biosciences
PrivateLast Round
VC Round
Jan 8, 2026
Total Funding Raised
$12.92M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alpenglow Biosciences is a life sciences company that provides a 3D spatial biology platform using AI-enabled imaging technology to accelerate drug development and improve clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Biotech Equipment, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alpenglow Biosciences Comparables
Compare Alpenglow Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LifeCanvas Technologies | 86% | |
| Stellaromics | 81% | |
| JelloX Biotech Inc. | 80% |
Alpenglow Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 8, 2026 | ||||
| Convertible Debt | Dec 31, 2025 | ||||
| VC Round | Aug 15, 2024 | ||||
| Grant | Aug 15, 2024 | ||||
| Grant | Aug 1, 2023 | ||||
Grant | Apr 11, 2022 |
Alpenglow Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dynamk Capital | Series A, VC Round |
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Washington Research Foundation Capital | Series A |
| Alexandria Venture Investments | Series A |
| First In Ventures | Series A |
| Andy Hill Cancer Research Endowment Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 25, 2026
Finalist for Innovation of the Year at the 2026 GeekWire Awards.
- Mar 25, 2026
Named a finalist for the Innovation of the Year award.
Alpenglow Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Alpenglow Biosciences's valuation, stock price, and market status.
Is Alpenglow Biosciences a public or private company?
Alpenglow Biosciences is a private company.
What is the current stock price of Alpenglow Biosciences?
Alpenglow Biosciences is a private company, so its shares have no public market price. Caplight tracks Alpenglow Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alpenglow Biosciences worth (valuation)?
Valuation information for Alpenglow Biosciences is not publicly available.
Can I buy Alpenglow Biosciences stock?
Alpenglow Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alpenglow Biosciences's last funding round?
Alpenglow Biosciences's most recent funding round was VC Round on January 8, 2026.
Who are the main investors in Alpenglow Biosciences?
Key investors in Alpenglow Biosciences include Dynamk Capital, Andy Hill Cancer Research Endowment Fund.
Will Alpenglow Biosciences IPO soon?
No public IPO plans have been announced for Alpenglow Biosciences.
How can I track Alpenglow Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Alpenglow Biosciences's shares on secondary markets.